Navigation Links
Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
Date:8/7/2014

f its plans will be achieved. Actual results may differ materially from those expressed or implied in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: the potential for the FDA to not approve NB32 even after meeting the prespecified threshold and resubmitting the NDA; the possibility that public disclosure of the results of the interim analysis of the Light Study would later be deemed to jeopardize the integrity of the Light Study potentially resulting in the requirement to conduct additional, costly studies; additional analysis of the interim results or new data from the continuing Light Study, including safety-related data, may produce negative or inconclusive results, or may be inconsistent with the conclusion that the interim analysis was successful; the potential that the interim analysis may not be predictive of future results in the Light Study; the results from the interim analysis may not be sufficient to successfully respond to the questions raised regarding safety of NB32; the possibility that the CHMP requests additional or new data to be provided; the possibility that the CHMP determines to not approve NB32; the potential for early termination of Orexigen's North American collaboration agreement with Takeda; the possibility that Orexigen is unable to find a partner for NB32 in territories outside of North America, the final results of the Light Study may not support continued approval of NB32; the therapeutic and commercial value of NB32; the potential for additional costly clinical trials needed for Empatic; and other risks described in Orexigen's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. Further information regarding these an
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast
2. Orexigen Announces June 10, 2014 PDUFA Action Date for Contrave
3. Orexigen Resubmits Contrave New Drug Application
4. Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
5. Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
6. Orexigen Announces Successful Interim Analysis of Contrave Light Study
7. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
8. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
9. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
10. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
11. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... BETHESDA, Md. , May 28, 2015 /PRNewswire-USNewswire/ ... that it will be a supporting organization of ... assurance and sterilization in 2016. Johnson ... a series of high-profile superbug infections in endoscopes. ... world health issues between 1976 and 2003 on ...
(Date:5/28/2015)... , May 28, 2015 Compassion & Choices today ... approved a bill that would authorize the option of medical ... 5-2. The ... , would allow mentally competent adults with six months or ... could take to painlessly and peacefully end an unbearable dying ...
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "Personalized ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... is to match the right drug to ... even to design the appropriate treatment for ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: ... Food Allergy Awareness Week (FAAW), May 8-14. Created by the ... to educate others and raise awareness about food allergies, a ... are the most common trigger of anaphylaxis,(3) a severe allergic ...
... Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: ... radiotherapy and diagnostic imaging centers in China, today announced that ... The Company will present at the 16th CLSA ... 2011 at the Grand Hyatt Hotel in Beijing. Management will ...
Cached Medicine Technology:Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 2Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 3Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 4Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 5Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 6Concord Medical Services Holdings to Present at Two Upcoming Conferences 2
(Date:5/29/2015)... The Bill Howe Family of Companies is ... air conditioning and restoration & flood services company. Family-owned and ... commitment to giving back to their community. They have been ... row from the Union Tribune Reader’s Poll, a Healthiest Company ... multi-year recognition as a Best Place to Work as well ...
(Date:5/29/2015)... May 28th, TheCelebrityDresses.com released their new range of exclusively ... of the styles in their new collection were priced ... styles of sexy cocktail dresses and 100 cheap bridesmaid ... with the new release are color blocks, exclusively designed ... the new styles are made of carefully selected fine ...
(Date:5/28/2015)... Recently, KORT Richmond, 5006 Atwood Drive, added a ... of life. The program works with those new to prosthetic ... but are still having difficulty. , According to the ... with limb loss in the United States. The main causes ... peripheral arterial disease – trauma (45%) and cancer (less than ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
(Date:5/28/2015)... AMVETS National Executive Director Stewart Hickey ... Care established by Congress to examine how to best ... to the commission by Mitch McConnell, majority leader of ... only 15 voting members on the panel, which was ... of 2014. The goal of the commission is to ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 2Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Richmond Physical Therapy Adds New Program to Help Amputees 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2
... a study published recently in the journal Science ... on the molecular level how the anti-malaria drug chloroquine ... strategies for treating inflammation and a multitude of autoimmune ... Chloroquine is a widely used anti-malaria drug that ...
... School of Medicine have identified how a gene for a ... nerve cells in the brain, thereby contributing to Alzheimer,s disease. ... (Abeta) in the brain. Abeta plays a key role in ... to Alzheimer,s disease and identified where the molecules lived in ...
... institute aimed at accelerating the pace of translating science ... from the National Institutes of Health to expand its ... Clinical and Translational Science Institute (CTSI) is among 10 ... of their successes during the first five years of ...
... money that hospitals spend on environmental services, such as ... influencing patient satisfaction scores as the way the money ... focusing on improving the efficiency of operations, hospitals can ... out of the financial investments they make toward support ...
... with older people with no signs of Alzheimer,s, those whose brains ... experience a fall, researchers have found. In the new study, ... participating in a study of memory and aging. The seniors were ... over the course of eight months. An increased risk of ...
... NFL football players are at higher risk for mild cognitive ... Loyola University Health System study has found. , A screening ... 35 percent of the players had scores suggesting possible mild ... appears there may be a very high rate of cognitive ...
Cached Medicine News:Health News:Chloroquine finding may lead to treatments for arthritis, cancer and other diseases 2Health News:Chloroquine finding may lead to treatments for arthritis, cancer and other diseases 3Health News:Researchers identify how a gene linked to both Alzheimer's disease and type 2 diabetes works 2Health News:UCSF receives $112 million to help translate science into cures 2Health News:UCSF receives $112 million to help translate science into cures 3Health News:UCSF receives $112 million to help translate science into cures 4Health News:Value of hospital environmental services linked to efficiency not expenses 2Health News:Value of hospital environmental services linked to efficiency not expenses 3Health News:Falls Could Signal Early Alzheimer's Disease 2Health News:Retired NFL players at higher risk for mild cognitive impairment 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: